Search research articles
Contact Us
Filters
Showing results (111-120 of 143) with videos related to
Page
of 15
Sort By:
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant
Rachel V Hatch, Craig W Freyer, Alison Carulli, et al.
Leukemia & Lymphoma
|
June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation
Craig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma
|
March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
Molly E Graveno, Alison Carulli, Craig W Freyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.
The Journal of Clinical Investigation
|
December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Ran Reshef, Austin P Huffman, Amy Gao, et al.
Blood
|
June 22, 2018
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma
Jakub Svoboda, Susan R Rheingold, Saar I Gill, et al.
American Journal of Hematology
|
April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents
Gee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Haematologica
|
April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
Matthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Transplantation and Cellular Therapy
|
May 9, 2021
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay
Craig W Freyer, Shannon Gier, Mary E Moyer, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 143) with videos related to
Sort By:
Page
of 15
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 22, 2022
Day 4 vs. day 12 G-CSF administration following reduced intensity peripheral blood allogeneic stem cell transplant
Rachel V Hatch, Craig W Freyer, Alison Carulli, et al.
Leukemia & Lymphoma
|
June 3, 2020
Venous thromboembolism following pegaspargase in adults receiving antithrombin supplementation
Craig W Freyer, Alison Carulli, Alex Ganetsky, et al.
Leukemia & Lymphoma
|
March 8, 2022
Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
Molly E Graveno, Alison Carulli, Craig W Freyer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 27, 2018
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky, Jennifer H Han, Mitchell E Hughes, et al.
The Journal of Clinical Investigation
|
December 18, 2019
CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Christopher L Nobles, Scott Sherrill-Mix, John K Everett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity Conditioning
Ran Reshef, Austin P Huffman, Amy Gao, et al.
Blood
|
June 22, 2018
Nonviral RNA chimeric antigen receptor-modified T cells in patients with Hodgkin lymphoma
Jakub Svoboda, Susan R Rheingold, Saar I Gill, et al.
American Journal of Hematology
|
April 4, 2020
Risk of invasive fungal infections in patients with high-risk MDS and AML receiving hypomethylating agents
Gee Youn Geeny Kim, Jonathan Burns, Craig W Freyer, et al.
Haematologica
|
April 18, 2024
Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia
Matthew P Connor, Neeharika Prathapa, Noelle V Frey, et al.
Transplantation and Cellular Therapy
|
May 9, 2021
Leucovorin Rescue After Methotrexate Graft-Versus-Host Disease Prophylaxis Shortens the Duration of Mucositis, Time to Neutrophil Engraftment, and Hospital Length of Stay
Craig W Freyer, Shannon Gier, Mary E Moyer, et al.
Page
of 15